Rebuilding trust in proton pump inhibitor therapy.

Introduction of proton pump inhibitor (PPI) therapy into clinical practice has revolutionized treatment approach to acid-related diseases. With its clinical success came a widespread use of PPI therapy. Subsequently, several studies found that PPIs were oftentimes overprescribed in primary care and emergency setting, likely attributed to seemingly low side-effect profile and physicians having low threshold to initiate therapy. However, now there is a growing concern over PPI side-effect profile among both patients and providers. We would like to bring more awareness to the currently available guidelines on PPI use, discuss clinical indications for PPIs and the evidence behind the reported side-effects. We hope that increased awareness of proper PPI use will make the initiation or continuation of therapy a well informed and an evidence-based decision between patient and physician. We also hope that discussing evidence behind the reported side-effect profile will help clarify the growing concerns over PPI therapy. ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.

Citation

Alla Turshudzhyan, Sonia Samuel, Angela Tawfik, Micheal Tadros. Rebuilding trust in proton pump inhibitor therapy. World journal of gastroenterology. 2022 Jun 28;28(24):2667-2679

Mesh Tags

Substances

PMID: 35979162

search → result